John Kane, MedThink Communications

Articles by John Kane, MedThink Communications

Driving Innovation: How Collaboration Between Medical Affairs and Commercial Teams Is Transforming the Industry

ByJohn Kane, MedThink Communications,Todd Parker, SVP, Managing Director, MedThink SciCom, a Fingerpaint Group Company

May 10th 2024

Unlocking a New Era of Key Opinion Leader Engagement: The Power of Digital Voices

ByJohn Kane, MedThink Communications,Mary McGregor, Managing Partner, Engage, a Fingerpaint company, Brand Insights Contributor

March 28th 2022

Brand Insights - Thought Leadership | Paid Program

Latest Updated Articles

Trending on PharmExec

Merck Licenses Preclinical KRAS G12D Inhibitor from SciBrunch

Roundup: FDA Approves Lilly’s Olumiant, AbbVie’s Juvmo, Mirum & Incyte’s Atebrioz

Pharming CEO Fabrice Chouraqui Steps Down Amid Strategic Disagreement with Board

New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report

Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal